{"nctId":"NCT02362789","briefTitle":"Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers","startDateStruct":{"date":"2015-01-04","type":"ACTUAL"},"conditions":["Psoriasis"],"count":132,"armGroups":[{"label":"Secukinumab","type":"EXPERIMENTAL","interventionNames":["Biological: Secukinumab"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Placebo"]}],"interventions":[{"name":"Secukinumab","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Key Inclusion Criteria:\n\n* Chronic moderate to severe plaque type psoriasis as diagnosed by a qualified physician at least 6 months prior to baseline and with a PASI score \\> 10 at baseline.\n* Psoriasis patients with pruritus intensity of â‰¥ 30 on a 100-point VAS, with a recall period of 24h as part of the PGA-CP, both, at screening and at baseline.\n\nKey Exclusion Criteria:\n\n* Underlying conditions other than psoriasis which in the opinion of the investigator currently cause or influence pruritus of the skin (e.g. drug induced pruritus, renal insufficiency, diabetes).\n* Forms of psoriasis other than chronic plaque-type (e.g., pustular, erythrodermic, and guttate) at screening or study start.\n* Ongoing use of prohibited psoriasis and non-psoriasis treatments. Washout periods have to be adhered to. If the use of any of the prohibited treatments is required, then the subject may not be included into the study.\n* Pregnancy, breast feeding or inadequate contraception (if necessary)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pruritus Intensity Visual Analogue Scale Score at Week 32","description":"On a 100-mm horizontal line, the patient placed a mark representing their perception of worst itching (pruritus) within a recall period of 24 hours, where 0 = no pruritus and 100 = most severe pruritus.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":"4.7"},{"groupId":"OG001","value":"27.1","spread":"4.9"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":130},"commonTop":["NASOPHARYNGITIS","HEADACHE","BACK PAIN","INFLUENZA","HYPERTENSION"]}}}